Scarica l'app Stockscreener
58.71
0.53%
-0.31
Dopo l'orario di chiusura:
58.35
-0.36
-0.61%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
9 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Bristol Myers Squibb-Pfizer Alliance to sell Eliquis on Mark Cuban’s Cost Plus Drugs - ROI-NJ
Bristol Myers Squibb (BMY) and Pfizer (PFE) Launch Eliquis on Co - GuruFocus
Bristol Myers Squibb Becomes Stable Choice for Defensive Portfolios - HarianBasis.co
Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios - Insider Monkey
Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy - Reuters
Milestone in Atrium and BMS cardiovascular collaboration - BioWorld News
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company - Yahoo Finance
Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade) - Seeking Alpha
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MSN
Multi-Manager Large Cap Growth Strategies Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
MFS Global Alternative Strategy Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol Myers Squibb donates lab equipment to Seton Hall - NJBIZ
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Milestone Asset Management LLC Invests $2.25 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Atrium Therapeutics earns $15M from Bristol Myers Squibb - Investing.com
Atrium lands $15M after delivering first heart drug candidate - Stock Titan
Bristol Myers Squibb files WARN notice for 206 jobs - ROI-NJ
Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca - GlobeNewswire Inc.
61,789 Shares in Bristol Myers Squibb Company $BMY Bought by CPC Advisors LLC - MarketBeat
Bristol-Myers Squibb Company stock (US0897961004): Why does its oncology dominance matter more now f - AD HOC NEWS
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? - Yahoo Finance
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock - Yahoo Finance
BMY Expands Partnership with Foundation Medicine for Diagnostic Development - GuruFocus
New cancer test aims to find patients with hard-to-detect MTAP deletion - Stock Titan
Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - GlobeNewswire Inc.
Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - GlobeNewswire Inc.
Bristol-Myers Squibb stock (US1078421011): Is its oncology dominance strong enough to unlock new ups - AD HOC NEWS
Lobbying Update: $1,320,000 of BRISTOL-MYERS SQUIBB COMPANY lobbying was just disclosed - Quiver Quantitative
AQR Equity Market Neutral Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors - MarketWatch
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1? - TradingView
Why Bristol Myers Squibb (BMY) is a Top Momentum Stock for the Long-Term - Yahoo Finance
The top 20 pharma companies by 2025 revenue - Fierce Pharma
BMY Technical Analysis | Trend, Signals & Chart Patterns | BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - ChartMill
Bristol Myers Squibb Stock Forecast: What’s Driving Focus - Kalkine Media
Assetmark Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb to cut 206 more jobs in New Jersey (updated) - NJBIZ
Bristol-Myers Squibb Company Solicits Proxies from Shareholders - marketscreener.com
Virtus Silvant Large-Cap Growth Stock Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Why Bristol Myers Squibb (BMY) outpaced the stock market today - MSN
Bristol Myers Squibb Company $BMY Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Bristol Myers Squibb (BMY) Institutional Ownership 2026 $BMY - MarketBeat
Bristol-Myers Squibb Announces the Early Results of its Cash Tender Offer For Up to $400 Million Aggregate Principal Amount o... - ADVFN
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today - Yahoo Finance
Bain Capital’s Beeline Medicines Emerges With Assets From Bristol Myers Squibb - citybiz
New Bain biotech startup, building on BMS drugs, gets a name and a CEO - statnews.com
Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers - BioPharma Dive
Raymond James reiterates Market Perform on Bristol-Myers stock - Investing.com
Raymond James reiterates Market Perform on Bristol-Myers stock By Investing.com - Investing.com Canada
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Massachusetts Financial Services Co. MA Increases Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Fidelity SAI U.S. Quality Index Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
F&V Capital Management, LLC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Is It Too Late To Reassess Bristol Myers Squibb (BMY) After Its Recent Share Price Rebound - Yahoo Finance
PIMCO Dividend and Income Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol Myers Squibb: Value Stock Analysis for Dividend Investors in 2026News and Statistics - IndexBox
Kirkland Advises Bristol-Myers Squibb on iPierian Buy - Law.com
Is Bristol-Myers Squibb Company (BMY) Among the 15 Cash-Rich Dividend Stocks to Invest in Right Now - Insider Monkey
American Express Company (AXP) – One of the 15 Cash-Rich Dividend Stocks to Invest in Right Now - Insider Monkey
Chemotherapy Market Set to Witness Massive Growth Through 2033 - openPR.com
Bristol Myers Squibb's Stock Position Boosted by Burney Co. - National Today
Bristol Myers Squibb Company $BMY Stock Position Lifted by Burney Co. - MarketBeat
Ritholtz Wealth Management Boosts Stake in Bristol Myers Squibb - National Today
Bristol Myers Squibb Downgraded to Buy Rating - National Today
Cantor Fitzgerald Reduces Stake in Bristol Myers Squibb - National Today
Wall Street Zen Downgrades Bristol Myers Squibb to Buy Rating - National Today
1.24%
2.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):